Cerebral catecholamine concentration after L-dopa therapy in Parkinson's disease.
D000368:Aged; D001923:Brain Chemistry; D002395:Catecholamines / Q000032:analysis*; D004295:Dihydroxyphenylalanine / Q000032:analysis / Q000627:therapeutic use*; D004298:Dopamine / Q000032:analysis; D005260:Female; D006801:Humans; D008875:Middle Aged; D009638:Norepinephrine / Q000032:analysis; D010300:Parkinson Disease / Q000188:drug therapy*; D009435:Synaptic Transmission
D002395:Catecholamines; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine